Altimmune (ALT) Non-Current Assets (2010 - 2026)

Altimmune (ALT) has reported Non-Current Assets for 17 consecutive years, with $954000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Assets fell 52.32% year-over-year to $954000.0; the TTM figure through Mar 2026 stood at $6.5 million (down 22.45% YoY), while the FY2025 annual figure was $1.7 million, down 15.35% from the prior year.
• Non-Current Assets declined to $954000.0 in Q1 2026 per ALT's latest filing, from $1.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $14.6 million in Q1 2022 and bottomed at $843000.0 in Q1 2024.
• Historically, Non-Current Assets has averaged $6.8 million across 5 years, with a median of $2.1 million in 2024.
• Annual changes were most pronounced in 2024 — Non-Current Assets tumbled 93.97% — and 2025, when it surged 137.37%.
• Altimmune's Non-Current Assets stood at $14.1 million in 2022, then plunged by 92.82% to $1.0 million in 2023, then soared by 102.37% to $2.1 million in 2024, then slipped by 15.35% to $1.7 million in 2025, then tumbled by 45.08% to $954000.0 in 2026.
• Business Quant data shows ALT's Non-Current Assets at $954000.0 in Q1 2026, $1.7 million in Q4 2025, and $1.8 million in Q3 2025.